abstract |
The invention relates to (E) - - [2-n-butyl-1 - [(4-carboxyphenyl) methyl] -1H-imidazol-5-yl] methylene-2-thiophenopropionic acid mono-methanesulfonate dihydrate, to a process for the preparation to compositions containing the compound and to methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure. |